Krystal Biotech Inc (STU:4KB) Transcripts
Q4 2023 Krystal Biotech Inc Earnings Call Transcript
Feb 26, 2024
€102
(-0.97%)
Earnings
Q3 2023 Krystal Biotech Inc Earnings Call Transcript
Nov 06, 2023
€113
(-0.88%)
Earnings
Krystal Biotech Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2023
Krystal Biotech Inc Research & Development Oncology Program Announcement Call Transcript
Jul 27, 2023
Krystal Biotech Inc at Goldman Sachs Healthcare Conference Transcript
Jun 13, 2023
Krystal Biotech Inc at William Blair Growth Stock Conference Transcript
Jun 06, 2023
Krystal Biotech Inc FDA Approval Call Transcript
May 19, 2023
Krystal Biotech Inc, Affyimmune Therapeutics Inc, Rocket Pharmaceuticals Inc and Iovance Biotherapeutics Inc at Endpoints Webinar on Moving CGTx Clinical Development- Panel Transcript
Mar 02, 2023
Krystal Biotech Inc at Bank of America Biotech SMID Cap Conference Transcript
Dec 07, 2022
Krystal Biotech Inc and Jeune Aesthetics Inc PEARL-1 Extension Cohort Results and the KB301 Clinical Development Program - Corporate Call Transcript
Nov 17, 2022
Krystal Biotech Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 15, 2022
Krystal Biotech Inc at Bank of America Healthcare Conference Transcript
May 10, 2022
Krystal Biotech Inc at Guggenheim Genomic Medicines and Rare Disease Day (Virtual) Transcript
Mar 31, 2022
Krystal Biotech Inc AAD GEM-3 Phase 3 Data Corporate Call Transcript
Mar 28, 2022
Krystal Biotech Inc KB301 Phase 1 POC Efficacy Data Update Call Transcript
Mar 22, 2022
Krystal Biotech Inc GEM-3 Phase 3 Topline Data Update Call Transcript
Nov 29, 2021
Krystal Biotech Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2021
Krystal Biotech Inc Annual Shareholders Meeting Transcript
May 21, 2021
Krystal Biotech Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 16, 2020
Krystal Biotech Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2020
Krystal Biotech Inc Annual Shareholders Meeting Transcript
May 29, 2020
Krystal Biotech Inc Phase 1/2 Clinical Trial of KB103 Final Update Call Transcript
Oct 29, 2019